Магнитно-лазерная терапия сопровождения в лечении онкогинекологических больных

the morphological pattern, the patient distribution was as follows: 69 (88.5%) patients with squamous cell carcinoma; 4 (5.1%) with adenocarcinoma; 4 (5.1%) with adenosquamous carcinoma; and 1 (1.3%) with mesonephric carcinoma. All the patients received combined radiotherapy. The P.A. Herzen Moscow Oncology Research Institute developed a procedure for accompanying laser therapy to prevent radiation-induced reactions (enterocolitis, rectitis, cystits), which was initiated on the first day of radiotherapy. The cycle of low-intensity magnetic laser therapy consisted of 15 sessions. The efficiency of accompanying laser therapy was evaluated from clinical findings (according to the RTOG classification of acute radiation lesions). Results. During radiotherapy, 24 (31%) of the 78 patients developed its induced reactions; grades I and II reactions being observed in 16 (21%) and 8 (10%) patients, respectively. In the solo radiotherapy group, the treatment break was in 5 patients: 1 and 3 days in 1 and 4 patients, respectively. After the radiation-induced reactions were abolished, the patients received a scheduled treatment volume. Grade III radiation-induced reactions were absent. Conclusion. Low-intensive accompanying magnetic laser therapy used in patients with cancer of the cervix uteri could reduce the frequency and degree of radiation-induced reactions, perform a radiotherapy cycle in the scheduled time, and improve quality of life in this patient group.